MedTrace Logo

Direct Peritoneal Resuscitation Plus Conventional Resuscitation

NCT01882218 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2017-05-05

No results posted yet for this study

Summary

The purpose of this study is to find out if direct peritoneal resuscitation (DPR) (putting a sugar solution into the abdominal cavity) helps blood flow through vital organs in the body that may suffer from low blood flow due to surgery. We will also try to find out if the DPR will help patients recover faster from liver surgery. Lastly, this study will also try to find if direct peritoneal resuscitation decreases levels of signaling chemicals in the blood called 'cytokines' and a protein called high-mobility group protein 1, which is known to cause tissue damage.

Conditions

  • Hepatic Cancer

Interventions

DRUG

Galactose

After surgery, galactose will be dripped into the belly for up to 24 hours after surgery

DRUG

Standard Treatment

Standard liver surgery.

Sponsors & Collaborators

  • University of Louisville

    lead OTHER

Principal Investigators

  • Jason Smith, MD · U Louisville

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01882218 on ClinicalTrials.gov